Dr. Antonio Marcilio Padula Omuro, MD

Dr. Omuro practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Omuro's NPI, 1912175134, was assigned on February 11, 2008. Dr. Omuro graduated from Universidade de Sao Paulo Faculty of Medicine in 1994. Dr. Omuro holds California license SFP51.

Dr. Omuro's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Omuro's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Omuro to 1 more hospital and 3 medical groups, each named with a free account. Dr. Omuro's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Omuro practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Omuro's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Dr. Omuro's licenses on file in 4 states: California, Connecticut, New York and Florida.

CMS data shows 73 Medicare services from Dr. Omuro across 2 procedure codes in 2024, for 28 Medicare patients. Medicare paid $5,894 for them.

CMS counts 28 Medicare patients who saw Dr. Omuro in 2024. 68% of them have high cholesterol, and 50% have high blood pressure. Their average risk score is 2.08, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Omuro's median patient age at 54, with 57% women.

In 2018, Dr. Omuro wrote 90 Medicare Part D claims. They cover 4 drugs, with $2,210 in total drug cost. In 2017, CMS named 44 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Omuro for performance year 2024, reported as part of a group. Dr. Omuro accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Omuro as offering telehealth.

Dmand AI links 152 papers to Dr. Omuro, published from 2006 to 2024. 2016 was the busiest year, with 12. The most frequent topics are Brain Neoplasms, Central Nervous System Neoplasms and Magnetic Resonance Imaging. Dr. Omuro has published most often in Neuro Oncol. Dr. Omuro's most frequent co-authors are Elena Pentsova, MD, Thomas Joseph Kaley, MD and Craig P. Nolan, MD.

Dmand AI links Dr. Omuro to 23 clinical trials, 10 of them phase 2 studies. 7 are still active or recruiting. Conditions studied include Glioblastoma, Astrocytoma and Oligodendroglioma. Memorial Sloan Kettering Cancer Center sponsors the most, 7.

CMS Open Payments shows 52 general payments to Dr. Omuro from 10 drug and device companies from 2016 to 2024. Consulting fees make up the largest share, 58% of the total. Merck Sharp & Dohme Corporation paid the most, $12,686.

Dr. Omuro graduated from Universidade de Sao Paulo Faculty of Medicine in 1994. Dr. Omuro is a member of ASCO.

Dr. Omuro is in network with 11 carriers, including Excellus BlueCross BlueShield, Blue Cross Blue Shield of Michigan and Cigna. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.